Регистрация | Вход в службу | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

danielraymond library [94 articles]

Статьи, недавно добавленные в библиотеку danielraymond .
  • Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.
    Int J Epidemiol, Vol. 34, No. 1. (February 2005), pp. 121-130.
    posted to haart hcv hiv mortality by danielraymond on 2006-09-21 19:03:26 as ** along with 1 person markpoliz
  • Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users.
    Epidemiol Infect (17 May 2006), pp. 1-7.
    by J Amin, M G G Law, J Micallef, M Jauncey, I VAN Beek, J M M Kaldor, G J J Dore
    posted to acute clearance hcv idu by danielraymond on 2006-09-21 18:56:32 as **
  • Compliance/Adherence, HIV, and the Critique of Medical Power
    Social Theory & Health, Vol. 2, No. 4., 315.
    by Eric Mykhalovskiy, Liza Mccoy, Michael Bresalier
    posted to adherence foucault hiv power by danielraymond on 2006-09-11 21:51:43 as ** along with 1 person zhlobko
  • Interventions to reduce HIV/AIDS stigma: what have we learned?
    AIDS Educ Prev, Vol. 15, No. 1. (February 2003), pp. 49-69.
    posted to hiv stigma by danielraymond on 2006-07-07 21:50:24 as read
  • The expert patient: Illness as practice
    Medicine, Health Care and Philosophy, Vol. 8, No. 2. (January 2005), pp. 165-171.
    by Andrew Edgar
    posted to expertise by danielraymond on 2006-07-05 21:23:41 as **
  • Care of the Self and Patient Participation in Genetic Discourse: A Foucauldian Reading of the Surgeon General's My Family Health Portrait Program
    Journal of Genetic Counseling, Vol. 14, No. 6. (December 2005), pp. 423-434.
    by Benjamin Bates
    posted to foucault genetics by danielraymond on 2006-07-05 20:34:20 as **
  • Duration of peginterferon therapy in acute hepatitis C: a randomized trial.
    Hepatology, Vol. 43, No. 5. (May 2006), pp. 923-931.
    by SM Kamal, KN Moustafa, J Chen, J Fehr, A Abdel Moneim, KE Khalifa, LA El Gohary, AH Ramy, MA Madwar, J Rasenack, NH Afdhal
    posted to acute duration hcv treatment by danielraymond on 2006-06-23 18:00:14 as ***
  • Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response.
    Gastroenterology, Vol. 130, No. 3. (March 2006), pp. 632-638.
    by SM Kamal, AE Fouly, RR Kamel, B Hockenjos, A Al Tawil, KE Khalifa, Q He, MJ Koziel, KM El Naggar, J Rasenack, NH Afdhal
    posted to acute hcv onset treatment by danielraymond on 2006-06-23 17:59:35 as ***
  • VX-950, a novel hepatitis C virus (HCV) NS3-4A protease inhibitor, exhibits potent antiviral activities in HCv replicon cells.
    Antimicrob Agents Chemother, Vol. 50, No. 5. (May 2006), pp. 1813-1822.
    by K Lin, RB Perni, AD Kwong, C Lin
    posted to hcv protease-inhibitor vx-950 by danielraymond on 2006-06-23 17:58:22 as ***
  • Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease.
    Antimicrob Agents Chemother, Vol. 50, No. 3. (March 2006), pp. 899-909.
    by RB Perni, SJ Almquist, RA Byrn, G Chandorkar, PR Chaturvedi, LF Courtney, CJ Decker, K Dinehart, CA Gates, SL Harbeson, A Heiser, G Kalkeri, E Kolaczkowski, K Lin, YP Luong, BG Rao, WP Taylor, JA Thomson, RD Tung, Y Wei, AD Kwong, C Lin
    posted to hcv protease-inhibitor vx-950 by danielraymond on 2006-06-23 17:57:45 as ***
  • Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034.
    Antiviral Res, Vol. 70, No. 2. (June 2006), pp. 28-38.
    posted to hcv protease-inhibitor resistance sch-503034 by danielraymond on 2006-06-23 17:56:56 as ***
  • Therapeutic misconception and the appreciation of risks in clinical trials.
    Soc Sci Med, Vol. 58, No. 9. (May 2004), pp. 1689-1697.
    by CW Lidz, PS Appelbaum, T Grisso, M Renaud
    posted to clinical-trials therapeutic-misconception by danielraymond on 2006-06-23 17:56:05 as **
  • Letting the Gini out of the bottle? Challenges facing the relative income hypothesis.
    Soc Sci Med, Vol. 54, No. 4. (February 2002), pp. 561-576.
    by GT Ellison
    posted to income-inequality relative-income ses by danielraymond on 2006-06-23 17:48:08 as **
  • Anthropological insights into the use of race/ethnicity to explore genetic contributions to disparities in health.
    J Biosoc Sci, Vol. 38, No. 1. (January 2006), pp. 83-102.
    by SM Outram, GT Ellison
  • Controlled drinking, harm reduction and their roles in the response to alcohol-related problems
    Addiction Research and Theory, Vol. 14, No. 1. (February 2006), pp. 7-18.
    by Nick Heather
    posted to alcohol controlled-drinking harm-reduction moderation by danielraymond on 2006-06-23 16:55:31 as ****
  • Amphetamine users in Amsterdam: Patterns of use and modes of self-regulation
    Addiction Research and Theory, Vol. 14, No. 2. (April 2006), pp. 159-188.
    posted to amphetamine amsterdam self-regulation by danielraymond on 2006-06-23 16:53:48 as **
  • Behavioural self-management with problem drinkers: One-year follow-up of a controlled drinking group treatment approach
    Addiction Research and Theory, Vol. 14, No. 1. (February 2006), pp. 35-49.
    by Joachim Koerkel
    posted to alcohol moderation by danielraymond on 2006-06-23 16:39:51 as ** along with 1 person craigtalbert
  • Obstacles to the adoption of low risk drinking goals in the treatment of alcohol problems in the United States: A commentary
    Addiction Research and Theory, Vol. 14, No. 1. (February 2006), pp. 19-24.
    by Mark B Sobell, Linda C Sobell
    posted to alcohol moderation by danielraymond on 2006-06-23 16:36:51 as **
  • Providers' HIV Prevention Discussions with HIV-Seropositive Injection Drug Users.
    AIDS Behav (26 April 2006)
    by James D Wilkinson, Wei Zhao, Scott Santibanez, Julia Arnsten, Amy Knowlton, Cynthia A Gómez, Lisa R Metsch,
    posted to hiv idu prevention by danielraymond on 2006-06-23 16:28:40 as ***
  • Intrahepatic Hepatitis C Virus Replication Correlates with Chronic Hepatitis C Disease Severity In Vivo
    J. Virol., Vol. 80, No. 5. (1 March 2006), pp. 2280-2290.
    by Sampa Pal, Margaret C Shuhart, Lisa Thomassen, Scott S Emerson, Tao Su, Nathan Feuerborn, John Kae, David R Gretch
    posted to hcv hiv intrehepatic replication by danielraymond on 2006-02-11 19:45:53 as ***
  • Associations Between Substance Use and Sexual Risk Among Very Young Men Who Have Sex With Men.
    Sex Transm Dis, Vol. Publish Ahead of Print (13 January 2006)
    by David D Celentano, Linda A Valleroy, Frangiscos Sifakis, Duncan A Mackellar, John Hylton, Hanne Thiede, Willi McFarland, Douglas A Shehan, Susan R Stoyanoff, Marlene Lalota, Beryl A Koblin, Mitchell H Katz, Lucia V Torian,
    posted to drugs msm risk sex by danielraymond on 2006-02-04 21:50:32 as **
  • Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Gut, Vol. 55, No. 2. (February 2006), pp. 266-274.
    posted to cd8 epitopes escape fitness hcv by danielraymond on 2006-01-29 19:02:02 as **
  • Do antiviral CD8+ T cells select hepatitis C virus escape mutants? Analysis in diverse epitopes targeted by human intrahepatic CD8+ T lymphocytes
    Journal of Viral Hepatitis, Vol. 13, No. 2. (February 2006), pp. 121-130.
    by H Komatsu, G Lauer, OG Pybus, K Ouchi, D Wong, S Ward, B Walker, P Klenerman
    posted to cd8 epitopes escape hcv by danielraymond on 2006-01-29 18:45:11 as **
  • Ethnic differences in the presentation of chronic hepatitis C
    Journal of Viral Hepatitis, Vol. 13, No. 2. (February 2006), pp. 116-120.
    by R Lepe, JE Layden-Almer, TJ Layden, S Cotler
    posted to hcv latino by danielraymond on 2006-01-29 18:42:27 as **
  • Hepatitis C and steatosis: a reappraisal
    Journal of Viral Hepatitis, Vol. 13, No. 2. (February 2006), pp. 73-80.
    posted to hcv steatosis by danielraymond on 2006-01-29 17:58:15 as **
  • Accumulation of dysfunctional effector CD8+T cells in the liver of patients with chronic HCV infection.
    J Hepatol (5 December 2005)
    by Carla Nisii, Massimo Tempestilli, Chiara Agrati, Fabrizio Poccia, Guido Tocci, Maria Antonella A Longo, Gianpiero D'Offizi, Roberto Tersigni, Oreste Lo L Iacono, Giorgio Antonucci, Alessandra Oliva
    posted to cd8 dysfunction hcv by danielraymond on 2006-01-29 17:47:29 as ***
  • Amantadine triple therapy for non-responder hepatitis C patients. Clues for controversies (ANRS HC 03 BITRI).
    J Hepatol (20 December 2005)
    by Marianne Maynard, Pierre Pradat, François Bailly, Frédéric Rozier, Chantal Nemoz, Si Nafa Si N Ahmed, Patrice Adeleine, Christian Trepo, And A French Multicenter Group
    posted to amantadine hcv non-responder by danielraymond on 2006-01-29 17:45:35 as **
  • Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients.
    Hepatology, Vol. 43, No. 1. (January 2006), pp. 100-107.
    by G Raimondo, MR Brunetto, P Pontisso, A Smedile, AM Maina, C Saitta, G Squadrito, N Tono,
    posted to coinfection hbv hcv hdv by danielraymond on 2006-01-29 17:34:51 as **
  • Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City.
    Ethn Dis, Vol. 14, No. 4. (2004), pp. 589-596.
    by CM Fuller, S Galea, S Blaney, DC Ompad, S Deren, D Des Jarlais, D Vlahov
    posted to idu pharmacy race syringe by danielraymond on 2005-11-20 20:32:41 as ***
  • HIV among injection drug users in large US metropolitan areas, 1998.
    J Urban Health, Vol. 82, No. 3. (September 2005), pp. 434-445.
    by SR Friedman, S Lieb, B Tempalski, H Cooper, M Keem, R Friedman, PL Flom
    posted to hiv idu by danielraymond on 2005-11-20 20:29:06 as ***
  • Scale-free networks and sexually transmitted diseases: a description of observed patterns of sexual contacts in Britain and Zimbabwe.
    Sex Transm Dis, Vol. 31, No. 6. (June 2004), pp. 380-387.
  • HIV partner notification in the United States: a national survey of program coverage and outcomes.
    Sex Transm Dis, Vol. 31, No. 12. (December 2004), pp. 709-712.
    by MR Golden, M Hogben, JJ Potterat, HH Handsfield
    posted to hiv partner_notification by danielraymond on 2005-11-17 20:45:58 as **
  • Disease contact tracing in random and clustered networks.
    Proc Biol Sci, Vol. 272, No. 1570. (7 July 2005), pp. 1407-1414.
    by IZ Kiss, DM Green, RR Kao
    posted to epidemiology by danielraymond on 2005-11-17 20:06:00 as **
  • New approaches to quantifying the spread of infection
    Nature Reviews Microbiology, Vol. 3, No. 7. (01 July 2005), pp. 529-536.
    by Louise Matthews, Mark Woolhouse
    posted to epidemiology by danielraymond on 2005-11-17 19:44:23 as **
  • Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis
    Journal of Viral Hepatitis, Vol. 12, No. 6. (November 2005), pp. 655-662.
    by A Judd, S Hutchinson, S Wadd, M Hickman, A Taylor, S Jones, JV Parry, S Cameron, T Rhodes, S Ahmed, S Bird, R Fox, A Renton, GV Stimson, D Goldberg
    posted to hcv idu prevalence risk by danielraymond on 2005-11-08 13:58:11 as **** along with 1 person norahpalmateer
  • Viral evolution of hepatitis C in injection drug users
    Journal of Viral Hepatitis, Vol. 12, No. 6. (November 2005), pp. 574-583.
    by L Dove, Y Phung, N Bzowej, M Kim, A Monto, TL Wright
    posted to hcv idu quasispecies reinfection by danielraymond on 2005-11-08 13:54:41 as ****
  • Impulsivity and methamphetamine use.
    J Subst Abuse Treat, Vol. 29, No. 2. (September 2005), pp. 85-93.
    by SJ Semple, J Zians, I Grant, TL Patterson
    posted to impulsivity methamphetamine by danielraymond on 2005-11-07 02:28:21 as **
  • Methamphetamine-using HIV-positive men who have sex with men: correlates of polydrug use.
    J Urban Health, Vol. 82, No. 1 Suppl 1. (March 2005)
    by TL Patterson, SJ Semple, JK Zians, SA Strathdee
    posted to hiv methamphetamine msm polydrug by danielraymond on 2005-11-07 02:27:34 as **
  • Reasons for Stopping Antiretrovirals Used in an Initial Highly Active Antiretroviral Regimen: Increased Incidence of Stopping due to Toxicity or Patient/Physician Choice in Patients with Hepatitis C Coinfection.
    AIDS Res Hum Retroviruses, Vol. 21, No. 9. (September 2005), pp. 743-752.
    posted to discontinuation haart hcv hiv toxicity by danielraymond on 2005-10-18 12:10:01 as ***
  • Intrahepatic CD8(+) T-cell failure during chronic hepatitis C virus infection.
    Hepatology, Vol. 42, No. 4. (October 2005), pp. 828-837.
    posted to cd8 chronic hcv intrahepatic by danielraymond on 2005-09-27 14:12:40 as ****
  • Testing four competing theories of health-protective behavior.
    Health Psychol, Vol. 12, No. 4. (July 1993), pp. 324-333.
    by ND Weinstein
    posted to behavior hbt health theory by danielraymond on 2005-09-16 06:05:34 as ** along with 2 people suizan rebekah
  • Effective methods to change sex-risk among drug users: a review of psychosocial interventions.
    Soc Sci Med, Vol. 57, No. 9. (November 2003), pp. 1593-1608.
    posted to drugs hiv interventions risk sex theory by danielraymond on 2005-09-16 05:40:23 as **
  • The status of evidence and outcomes in Stages of Change research.
    Health Educ Res, Vol. 15, No. 6. (December 2000), pp. 707-718.
    posted to health soc ttm by danielraymond on 2005-09-16 04:59:33 as **
  • Why don't stage-based activity promotion interventions work?
    Health Educ Res, Vol. 20, No. 2. (April 2005), pp. 237-243.
    by J Adams, M White
    posted to soc ttm by danielraymond on 2005-09-16 04:56:50 as **
  • A comparison of injection and non-injection methamphetamine-using HIV positive men who have sex with men.
    Drug Alcohol Depend, Vol. 76, No. 2. (11 November 2004), pp. 203-212.
    by SJ Semple, TL Patterson, I Grant
    posted to hiv idu methamphetamine msm by danielraymond on 2005-09-16 04:40:35 as **
  • The utility of the Transtheoretical Model of behavior change for HIV risk reduction in injection drug users.
    J Assoc Nurses AIDS Care, Vol. 11, No. 1. (b 2000), pp. 57-66.
    posted to hiv idu soc ttm by danielraymond on 2005-09-16 03:19:59 as **
  • Stages of change. A critique.
    Behav Modif, Vol. 26, No. 2. (April 2002), pp. 223-273.
    by JH Littell, H Girvin
    posted to soc ttm by danielraymond on 2005-09-16 02:32:47 as **
  • Stages and processes of change as predictors of drug use among methadone maintenance patients.
    Exp Clin Psychopharmacol, Vol. 5, No. 1. (February 1997), pp. 65-73.
    by MA Belding, MY Iguchi, RJ Lamb
    posted to methadone soc ttm by danielraymond on 2005-09-16 01:20:32 as **
  • Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical bayesian meta-analysis.
    Vaccine (30 August 2005)
    by Norah J J Shire, Jeffrey A A Welge, Kenneth E E Sherman
    posted to efficacy hav hiv vaccine by danielraymond on 2005-09-13 14:02:18 as **
  • Changes in the sharing of drug injection equipment among street-recruited injection drug users in Chicago, Illinois, 1994--1996.
    Subst Use Misuse, Vol. 40, No. 1. (2005), pp. 63-76.
    by D Huo, SL Bailey, RS Garfein, LJ Ouellet
    posted to chicago cooker hiv idu sep sharing syringe by danielraymond on 2005-09-04 19:23:00 as ****
  • Вы можете ссылаться на эту страницу по адресу: http://www.citeulike.org/user/danielraymond

    Result page: 1 2 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.